or Try an Advanced Search...

    Alipogene Tiparvovec Stocks List

    Symbol Grade Name % Change
    XENE D Xenon Pharmaceuticals Inc. -1.07
    QURE F uniQure N.V. -0.85
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Gene Therapy Glybera Lipase Lipoprotein Lipoprotein Lipase Deficiency Acne Acute Intermittent Porphyria Adeno Associated Virus Analgesics Applied Genetics Biology Cardiovascular Disease Chemical Compounds Clinical Development Disease Erythromelalgia Gene Delivery Genetics Hemophilia

    Related ETFs - A few ETFs which own one or more of the above listed Alipogene Tiparvovec stocks.

    Symbol Grade Name Weight
    IBRN D iShares Neuroscience and Healthcare ETF 4.15
    PBE D PowerShares Dynamic Biotech & Genome 2.45
    SBIO D ALPS Medical Breakthroughs ETF 2.1
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 1.27
    MMSC C First Trust Multi-Manager Small 0.84
    View all Alipogene Tiparvovec ETFs...
    Compare ETFs
    Compare BBC to MMSC Compare IBRN to BBC Compare IBRN to MMSC

        Alipogene Tiparvovec Stocks Recent News

        Date Stock Title
        Apr 16 XENE Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Gene Therapy Glybera Lipase Lipoprotein Lipoprotein Lipase Deficiency Acne Acute Intermittent Porphyria Adeno Associated Virus Analgesics Applied Genetics Biology Cardiovascular Disease Chemical Compounds Clinical Development Disease Erythromelalgia Gene Delivery Genetics Hemophilia
        Alipogene Tiparvovec

        Alipogene Tiparvovec is a gene therapy drug used to treat lipoprotein lipase deficiency (LPLD). It is a one-time injection that is designed to replace the defective gene responsible for the condition. It is the first gene therapy approved by the US Food and Drug Administration (FDA) for the treatment of a genetic disorder.

        Browse All Tags